Market News

The Sentence of Michael Thompson” trailer earned a Silver Clio for creative excellence in filmvideo Cresco Labs a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced “The Sentence of Michael Thompson” documentary trailer earned a Silver Clio for Film & Video from the Clio Cannabis Awards. In addition, the Discover Some Wonder podcast series ...

"The Sentence of Michael Thompson" trailer earned a Silver Clio for creative excellence in film/video

Cresco Labs (CSE:CL) (OTCQX:CRLBF) ("Cresco Labs" or "the Company"), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced "The Sentence of Michael Thompson" documentary trailer earned a Silver Clio for Film & Video from the Clio Cannabis Awards. In addition, the Discover Some Wonder podcast series from the Company's Wonder Wellness cannabis brand and the #Wayto420 campaign from its Sunnyside retail brand were shortlisted for Digital & Mobile and Public Relations creative excellence, respectively.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211208005677/en/

"The Sentence of Michael Thompson" documentary trailer earned a Silver Clio from the 2021 Clio Cannabis Awards, the most prestigious program honoring marketing & communications work. (Graphic: Business Wire)

Expanding on Clio's longstanding reputation for establishing best-in-class programs honoring creative excellence in a variety of specialized verticals, the Clio Cannabis Awards—now in its third year—honors work and talent that builds a greater understanding of a rapidly growing industry.

"It is an honor for our efforts to be recognized for the second consecutive year by such a prestigious platform. Top recognition for ‘The Sentence of Michael Thompson' is very special because social equity and social justice are core to the company's mission, and the film aims to help people truly understand the gravity of the impact of injustice on the lives of people adversely impacted by The War on Drugs," said Cory Rothschild, SVP of Marketing.

Chima Enyia, EVP of SEED, added, "We appreciate all those involved—Michael Thompson, his family, restorative justice partners and our staff—in the making of this film. More than 40,000 Americans remain in prison for cannabis offenses, and there is much more work to do to right the wrongs of The War on Drugs. We are laser-focused on leveraging our platform and influence to drive awareness of Michael's story to ensure conversations about legalization address pardoning those currently incarcerated for cannabis offenses and social equity in the cannabis industry."

On Juneteenth, Cresco released the trailer for "The Sentence of Michael Thompson" , a documentary short film about the story of Michigan's longest-serving non-violent offender. Granted clemency this past January, Thompson was serving a 60-year sentence in Muskegon Correctional Facility in Michigan for selling 3 pounds of cannabis to a police informant in 1994. The trailer earned the Silver Clio for Film & Video. The documentary will be released in 2022.

Launched in August for National Wellness Month, Wonder Wellness created a one-of-a-kind audio collection designed to help listeners Focus, Relax, Laugh or Sleep, the experiences delivered by its gummy and minis products. The Discover Some Wonder initiative was named a shortlist winner for Digital & Mobile.

Timed with this year's 420 holiday, Sunnyside released the results of a nationwide survey that demonstrated shifting beliefs and behaviors surrounding cannabis use and translated them into approachable messages about the plant's functional benefits for every type of consumer. The #Wayto420 campaign was shortlisted in the Public Relations category.

To view the full gallery of winning work, visit www.cliocannabisawards.com .

About Cresco Labs Inc.

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods ("CPG") approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs' national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry's largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com .

Forward Looking Statements

This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,' ‘will,' ‘should,' ‘could,' ‘would,' ‘expects,' ‘plans,' ‘anticipates,' ‘believes,' ‘estimates,' ‘projects,' ‘predicts,' ‘potential' or ‘continue' or the negative of those forms or other comparable terms. The Company's forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under "Risk Factors" in the Company's Annual Information Form for the year ended December 31, 2020 filed on March 26, 2021, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company's forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco Labs' shares, nor as to the Company's financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company's forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investor Relations:
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

News Provided by Business Wire via QuoteMedia

business meeting evaluating financial results

Cannabis Weekly Round-Up: Organigram Results Improve, Ascend Ready for Lawsuit

A Canadian cannabis producer beat estimates in its latest financial results, and experts believe it may be showing signs of achieving profitability.

Also this week, Ascend Wellness Holdings (AWH) (CSE:AAWH.U,OTCQX:AAWH) revealed it will be taking its dispute with MedMen Enterprises (CSE:MMEN,OTCQX:MMNFF) to court.

Keep reading to find out more cannabis highlights from the past five days.

Keep reading... Show less
Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product

Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary Psilocybin Product

The trial evaluates Numinus' first trademarked product and patent-pending production process

 Numinus Wellness Inc. ("Numinus") (TSX: NUMI), a leader in psychedelics-focused mental healthcare, is pleased to announce that it has formally submitted the clinical trial application ("CTA") to Health Canada for its Phase 1 study, HOPE, on a naturally derived Psilocybe extract formulation, NBIO-01. This milestone further progresses and solidifies Numinus' long-standing work on developing safe and effective psychedelic products out of its Health Canada-licensed research facility, Numinus Bioscience.

Keep reading... Show less
Avicanna Enters Master Supply Agreement with Chilean Pharmaceutical Pioneer Knop Laboratorios S.A.

Avicanna Enters Master Supply Agreement with Chilean Pharmaceutical Pioneer Knop Laboratorios S.A.

Expansion and fortification of relationship since 2020 with established pharmaceutical company in Chile

Supply of Avicanna's active pharmaceutical ingredients for existing commercial and pipeline of pharmaceutical products in South America

Keep reading... Show less
Numinus Announces Cancellation and Rescheduling of Annual General Meeting of Shareholders

Numinus Announces Cancellation and Rescheduling of Annual General Meeting of Shareholders

Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, announced today that its annual general meeting of shareholders (the "AGM"), which was originally scheduled to be held on Friday, January 21, 2022 has been cancelled and rescheduled to be held on February 28 2022. The Company's Board of Directors determined that it would be in the best interests of the Company to reschedule the AGM for a variety of reasons, including a change to at least one resolution.

Further details on the AGM will be contained in a new Notice of Meeting and Management Information Circular that will be mailed to shareholders of the Company and filed on SEDAR.

Keep reading... Show less

IIROC Trade Resumption - CL

Trading resumes in:

Company: Cresco Labs Inc.

Keep reading... Show less

IIROC Trading Halt - CL

The following issues have been halted by IIROC:

Company: Cresco Labs Inc.

Keep reading... Show less

Latest Press Releases

Related News

×